| Old Articles: <Older 6481-6490 Newer> |
|---|
 |
The Motley Fool
July 23, 2010
Jordan DiPietro |
Better Health Care Buy: Stryker or Zimmer Holdings? Which stock is a better purchase to consider?   |
The Motley Fool
July 23, 2010
Luke Timmerman |
Momenta Gets FDA Green Light for Generic Anti-Clotting Drug The FDA says "yes" to Momenta Pharmaceuticals. |
The Motley Fool
July 23, 2010
Brian Orelli |
Eli Lilly Looks Great Today, but I'm Concerned About Tomorrow Eli Lilly is firing on all cylinders, but is there a blowout in its future? |
The Motley Fool
July 23, 2010
Bryan White |
3 Buys Suffering From the Health-Care Hangover Three ideas in value territory for a much-needed sector. |
The Motley Fool
July 22, 2010
Rich Smith |
This Just In: Upgrades and Downgrades Baird turns bullish on Human Genome Sciences. |
The Motley Fool
July 22, 2010
Brian Orelli |
One Surgery Dominated, A Hundred More to Go Intuitive Surgical isn't slowing down. |
The Motley Fool
July 22, 2010
Brian Orelli |
It's All About the Future for Amylin Its second quarter stank, but there's a lot up ahead. |
The Motley Fool
July 21, 2010
Brian Orelli |
15% Revenue Growth Is Good for Pfizer, but Not Gilead Gilead needs to reaccelerate growth. |
The Motley Fool
July 21, 2010
Brian Orelli |
Boston Scientific Bounces When you're as beaten-down as Boston Scientific, you seemingly have nowhere to go but up. There's also bankruptcy, but the beleaguered medical device maker seems far from that -- at least for now. |
The Motley Fool
July 21, 2010
Brian Orelli |
Biogen Looks Good Now, but What About Tomorrow? Biogen Idec saw revenue increase 11% and adjusted earnings per share jump almost 75%, which is all well and good, but the longer-term prospects for the company aren't nearly as impressive. |
| <Older 6481-6490 Newer> Return to current articles. |
